PINNA, Antonio Daniele
 Distribuzione geografica
Continente #
NA - Nord America 6.847
AS - Asia 3.461
EU - Europa 2.529
SA - Sud America 562
AF - Africa 99
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.506
Nazione #
US - Stati Uniti d'America 6.744
SG - Singapore 1.132
CN - Cina 742
HK - Hong Kong 605
GB - Regno Unito 503
VN - Vietnam 456
BR - Brasile 406
SE - Svezia 376
PL - Polonia 361
FI - Finlandia 285
IT - Italia 229
DE - Germania 202
RU - Federazione Russa 169
IN - India 97
FR - Francia 90
KR - Corea 78
BG - Bulgaria 76
TR - Turchia 74
AR - Argentina 73
UA - Ucraina 73
NL - Olanda 55
CA - Canada 50
BD - Bangladesh 49
JP - Giappone 33
ID - Indonesia 32
EC - Ecuador 26
ZA - Sudafrica 26
IQ - Iraq 25
MX - Messico 25
PK - Pakistan 25
AE - Emirati Arabi Uniti 22
CO - Colombia 19
IE - Irlanda 19
LT - Lituania 19
EG - Egitto 17
AT - Austria 16
MY - Malesia 16
ES - Italia 15
MA - Marocco 12
TN - Tunisia 12
CL - Cile 9
JO - Giordania 9
KE - Kenya 9
PE - Perù 9
PH - Filippine 9
SA - Arabia Saudita 9
KZ - Kazakistan 8
NP - Nepal 8
TH - Thailandia 8
VE - Venezuela 8
CZ - Repubblica Ceca 7
BE - Belgio 6
DZ - Algeria 6
CR - Costa Rica 5
ET - Etiopia 5
TT - Trinidad e Tobago 5
UZ - Uzbekistan 5
AU - Australia 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
NO - Norvegia 4
PR - Porto Rico 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
CH - Svizzera 3
IR - Iran 3
NG - Nigeria 3
OM - Oman 3
PT - Portogallo 3
PY - Paraguay 3
SN - Senegal 3
UY - Uruguay 3
AL - Albania 2
IL - Israele 2
QA - Qatar 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
SM - San Marino 2
SV - El Salvador 2
AO - Angola 1
BB - Barbados 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CD - Congo 1
CG - Congo 1
CU - Cuba 1
CV - Capo Verde 1
DK - Danimarca 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
Totale 13.495
Città #
Santa Clara 934
Ashburn 676
Singapore 667
Hong Kong 584
Fairfield 556
Chandler 477
Warsaw 354
Woodbridge 300
Houston 285
Nyköping 282
Helsinki 261
Wilmington 241
San Jose 208
Southend 206
Seattle 203
London 180
Beijing 172
New York 163
Cambridge 162
Ho Chi Minh City 135
Chicago 132
Ann Arbor 127
Jacksonville 122
Los Angeles 122
The Dalles 107
Hanoi 106
Dearborn 96
Council Bluffs 84
Princeton 76
Seoul 76
Sofia 74
Shanghai 70
Hefei 64
Bremen 63
Jersey City 60
San Diego 59
Salt Lake City 58
São Paulo 46
Modena 43
Orem 41
Moscow 40
Izmir 36
Milan 36
Lauterbourg 32
Dallas 31
Tampa 31
Buffalo 30
Tokyo 29
Elk Grove Village 27
Eugene 27
Haiphong 25
Da Nang 24
Des Moines 24
Groningen 22
Chennai 20
Redwood City 19
Amsterdam 18
Biên Hòa 17
Dublin 17
Johannesburg 17
Kilburn 17
Stockholm 17
Bologna 16
Jakarta 16
Redondo Beach 16
Phoenix 15
Columbus 14
Denver 14
Atlanta 13
Frankfurt am Main 13
Montreal 13
Long Branch 12
Mumbai 12
North Charleston 12
Manchester 11
Munich 11
San Mateo 11
Sterling 11
Brasília 10
Cairo 10
Lancaster 10
Quito 10
Rio de Janeiro 10
Vienna 10
Augusta 9
Baghdad 9
Buenos Aires 9
Kunming 9
New Delhi 9
Norwalk 9
Paris 9
Poplar 9
Toronto 9
Vancouver 9
Amman 8
Falls Church 8
Goiânia 8
Lahore 8
Mexico City 8
Nairobi 8
Totale 9.636
Nome #
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study. 659
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study. 340
Intestinal autotransplantation for adenocarcinoma of pancreas involving the mesenteric root: Our experience and literature review 321
Procurement technique for isolated small bowel, pancreas, and liver from multiorgan cadaveric donor 312
A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18. 302
De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients 299
Essential oils in ocular pathology: an experimental study 295
Pretransplantation pre-S2 and S protein heterogeneity predisposes to hepatitis B virus recurrence after liver transplantation 287
Use of prosthetic mesh in difficult abdominal waal closure after small bowel transplantation in adults. 276
Multicenter Italian Experience in Liver Transplantation for Hepatocellular Carcinoma in HIV-Infected Patients 272
Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 434 Patients. 269
Effects of mycophenolate mofetil introduction in liver transplant patients: results from an observational, non-interventional, multicenter study (LOBSTER). 266
Comparison of the prognostic accuracy of the sixth and seventh editions of the TNM classification for intrahepatic cholangiocarcinoma. 261
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. 242
High dose rabbit antithymocyte globulin induction in living related liver transplantation. 240
Salvage liver transplantation after laparoscopic resection for hepatocellular carcinoma: a multicenter experience 234
Liver transplantation and hepatic resection can achieve cure for hepatocellular carcinoma 224
Orthogonal Polarization Spectral (OPS) Imaging: A New Tool in Morphologic Surveillance in Intestinal Transplant Recipients 216
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients 215
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 215
Small intestine microflora after intestinal/multivisceral transplantation: Preliminary results 205
Multicentre evaluation of case volume in minimally invasive hepatectomy 200
Donor safety in living donor liver donation: An Italian multicenter survey 198
Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study 198
Modified multivisceral transplantation without liver for Gardner desmoid syndrome and cronic intestinal pseudoobstruction 191
Haemodinamic changes in living-related liver transplant: a colour-doppler ultrasound study. . 186
La terapia chirurgica dell’HCC nel paziente anziano. 184
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation 182
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: A real-life strategy 175
Haemodinamic changes in living-related liver transplant: a colour-doppler ultrasound study. . 174
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients 174
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma 172
G-CSF administration is not related to Peg-IFN alfa-2b treatment duration nor response in liver transplanted patients with HCV recurrence 171
Metronomic capecitabine in advanced hepatocellular carcinoma patients:a phase II study 170
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 170
Clinical Impact and behaviour of serum autoantibodies in adult liver transplantation 168
Long-term antiviral treatment for recurrent hepatitis C after liver transplantation 168
Assessment of Radiofrequency Ablation Efficacy for Hepatocellular Carcinoma by Histology and Pre-transplant Radiology 162
Sirolimus-Tacrolimus combined immunosuppression and early steroidal withdrawal in liver transplantation. 157
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma 156
Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from a 20-year multicentre experience in Italy 154
Retrospective analysis of resectability, prognostic factors and outcome of cholangiocellular carcinoma (CCC) 153
Liver resection for perihilar cholangiocarcinoma: Impact of biliary drainage failure on postoperative outcome. Results of an Italian multicenter study 153
G-CSF administration is not related to PEG-IFN alfa-213 treatment duration nor response in liver transplanted patients with HCV recurrence 151
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? 151
Improved Survival in Liver Transplant Patients Receiving Prolonged-release Tacrolimus-based Immunosuppression in the European Liver Transplant Registry (ELTR): An Extension Study 148
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 147
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 147
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 146
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool 145
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? 144
MARS and Prometheus: our clinical experience in acute chronic liver failure 143
Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection 141
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 137
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 136
Metronomic capecitabine as second-line treatment for patients with hepatocellular carcinoma with preserved liver function: A phase II study 135
Detection of HCV antigens in liver graft: Relevance to the management of recurrent post-liver transplant hepatitis C 135
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation 133
Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature 131
Metronomic capecitabine in advanced hepatocellualr cacinoma patients who have failed sorafenib: a phase II study 126
High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? 119
Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma 119
Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant 116
Two yr mycophenolate mofetil plus low-dose calcineurin inhibitor for renal dysfunction after liver transplant 112
Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience 111
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation 107
Impact of hepatitis C virus infection on health-related quality of life before and after liver transplantation: a multidisciplinary point of view 104
Liver Transplantation for Hepatic Trauma: A Study from the European Liver Transplant Registry 102
The role of Spleen Stiffness measurement as predictor of HCC recurrence after curative resection in cirrhotic patients 102
Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma 93
Surgical overview on kidney and pancreas transplantation [Problemi chirurgici nel trapianto di rene e di pancreas - Position paper] 88
THU-086 - The role of spleen stiffness measurement as predictor of hepatocellular carcinoma recurrence after curative resection in cirrhotic patients 82
Reply to Letter:'Value of transient elastography measured by Fibroscan in predicting the outcome of hepatic resection for hepatocellular carcinoma' 81
SPONTANEOUS MOBILIZATIONOF BONE MARROW-DERIVED HEMATOPOIETIC AND ENDOTHELAIL PROGENITOR CELLS AFTER ORTHOTOPIC LIVER TRANSPALNTATION (OLT) 80
ABDOMINAL WALL TRANSPLANTATION WITH MICROSURGICAL TECHNIQUE 37
Totale 13.615
Categoria #
all - tutte 62.336
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.336


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021206 0 0 0 0 0 0 0 0 0 0 153 53
2021/20221.209 106 109 49 38 26 67 95 57 162 102 267 131
2022/20231.346 175 180 106 108 182 215 22 109 165 6 39 39
2023/2024747 29 42 36 69 158 62 62 98 42 10 46 93
2024/20252.692 96 15 10 199 636 396 122 244 359 114 178 323
2025/20265.177 263 157 341 702 977 726 666 298 520 466 61 0
Totale 13.615